# Early Versus Delayed BCG Vaccination of HIV-exposed Infants

> **NCT02062580** · PHASE2 · COMPLETED · sponsor: **University of Cape Town** · enrollment: 149 (actual)

## Conditions studied

- HIV Exposure
- HIV Infection

## Interventions

- **BIOLOGICAL:** BCG

## Key facts

- **NCT ID:** NCT02062580
- **Lead sponsor:** University of Cape Town
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-04
- **Final completion:** —
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2017-03-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062580, "Early Versus Delayed BCG Vaccination of HIV-exposed Infants". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02062580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*